Hu S, Dan W, Liu J, Ha P, Zhou T, Guo X, et al
Dissecting the heterogeneity in T-cell mediated inflammation in IBD
Ngun gc xut x r rng, nguyn liu nhp khu Quy trnh nghin cu v ra mt cho mt dng sn phm t nht 10-12 thng Khng th nghim trn ng vt, bo v mi trng Sn xut khp kn an ton, v sinh Bo hnh chnh hng m bo quyn v li ch ca khch hng khi mua sn phm ti ZEE y giy kim nghim cht lng, kim nghim cht cm (khng cha Corticoid, Thu Ngn), giy cng b ca S Y T
The progression from single-agonist (semaglutide) to dual-agonist (tirzepatide) to triple-agonist (retatrutide) tells a clear story about where obesity treatment is heading
Changes are quite likely more related to increased systemic inflammation, BBB disruption, and cognitive outcome deterioration (Silva et al., 2020)